Kymera Therapeutics KYMR Purchases Of Property And Equipment Through Finance And Lease Liabilities
Purchases Of Property And Equipment Through Finance And Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept kymr:PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities.
The official record: Kymera Therapeutics’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's purchases of property and equipment through finance and lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's purchases of property and equipment through finance and lease liabilities?
- Kymera Therapeutics (KYMR) reported purchases of property and equipment through finance and lease liabilities of $257K in Q4 2025.
- How has Kymera Therapeutics's purchases of property and equipment through finance and lease liabilities changed year-over-year?
- Kymera Therapeutics's purchases of property and equipment through finance and lease liabilities decreased by 62.5% year-over-year, from $685.5K to $257K.
- What is the long-term trend for Kymera Therapeutics's purchases of property and equipment through finance and lease liabilities?
- Over 4 years (2021 to 2025), Kymera Therapeutics's purchases of property and equipment through finance and lease liabilities has grown at a -14.4% compound annual growth rate (CAGR), from $1.92M to $1.03M.
- What does purchases of property and equipment through finance and lease liabilities mean?
- Tracks the acquisition of property and equipment financed through specific lease or credit arrangements rather than direct cash purchases. This highlights the company's use of alternative financing structures to build out operational capacity.